| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,120 | 16,526 | 15,015 | 16,471 | | Cost of Revenue | 7,248 | 3,171 | 3,562 | 4,276 | | | Gross Profit |
-
| 13,355 | 11,453 | 12,195 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,023 | 7,956 | 7,342 | 7,572 | | Non Recurring |
-
| (248) | 248 | (140) | | Others | (1,910) | 2,251 | 1,766 | 3,141 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,396 | 2,097 | 1,622 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 7,759 | 3,396 | 2,097 | 1,622 | | Interest Expense | 1,732 | 1,153 | 1,140 | 1,245 | | Income Before Tax | 6,027 | 2,243 | 957 | 377 | | Income Tax Expense | 2,019 | 883 | 332 | (20) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,008 | 1,360 | 625 | 398 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,008 | 1,360 | 625 | 398 | | Preferred Stock And Other Adjustments | 550 | (349) | (201) |
-
| | | Net Income Applicable To Common Shares | $4,558 | $1,011 | $424 | $398 |
|
0.03% Nasdaq 0.00%
Income Statement
